Active-site mobility in human immunodeficiency virus, type 1, protease as demonstrated by crystal structure of A28S mutant

Protein Science

Volumn 7, Issue 2, 1998, Pages 300-305

  Hong, Lin ^a   Hartsuck, Jean A ^a,b   Foundling, Steve ^a,d   Ermolieff, Jacques ^a   Tang, Jordan ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Active site; HIV protease; Mutation

Indexed keywords

PROTEINASE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME IMMOBILIZATION; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS MUTATION;

EID: 0031915558     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070209     Document Type: Article

References (25)

1. Abad-Zapatero C, Rydel TJ, Erickson J. 1990. Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain. Proteins Struct Funct Genet 8:62-81.
2. Blaber M, Zhang XJ, Lindstrom JD, Pepiot SD, Baase WA, Matthews BW. 1994. Determination of alpha-helix propensity within the context of a folded protein. J Mol Biol 235:600-624.
3. Cooper JB, Khan G, Taylor G, Tickle IJ, Blundell TL. 1990. X-ray analyses of aspartic proteinases II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 Å resolution. J Mol Biol 214:199-222.
4. Davies DR. 1990. The structure and function of aspartic proteinases. Annu Rev Biophys Biophys Chem 19:189-215.
5. Debouck C, Gomiak JG, Strickler JE, Meek TD, Metcalf BW, Rosenberg M. 1987. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of gag precursor. Proc Natl Acad Sci USA 84:8903-8907.
6. Ermolieff J, Lin X, Tang J. 1997. Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo. Biochemistry 36:12364-12370.
7. Fujinaga M, Chernaia MM, Tarasova NI, Mosimann SC, James MN. 1995. Crystal structure of human pepsin and its complex with pepstatin. Protein Sci 4:960-972.
8. Graves MC, Lim JJ, Heimer EP, Kramer RA. 1988. An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity. Proc Natl Acad Sci USA 85:2449-2453.
9. Hansen J, Billich S, Schulze T, Sukrow S, Moelling K. 1988. Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. EMBO J 7:1785-1791.
10. Hong L, Treharne A, Hartsuck JA, Foundling S, Tang J. 1996. Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases. Biochemistry 35:10627-10633.
11. Ido E, Han HP, Kezdy FJ, Tang J. 1991. Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S. J Biol Chem 266:24359-24366.
12. Jones TA, Zou JY, Cowan SW, Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119.
13. Lapatto R, Blundell T, Hemmings A, Overington J, Wilderspin A, Wood S, Merson JR, Whittle PJ, Danley DE, Geoghegan KF, Hawrylik SJ, Lee SE, Scheld KG, Hobart PM. 1989. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature 342:299-302.
14. Laskowski RA, Mac-Arthur MW, Moss DS, Thornton JM. 1993. A program to check the stereo chemical quality of protein structures. J Appl Crystallogr 26:283-291.
15. Lin Y, Fusek M, Lin X, Hartsuck JA, Kezdy FJ, Tang J. 1992. pH Dependence of kinetic parameters of pepsin, rhizopuspepsin, and their active-site hydrogen bond mutants. J Biol Chem 267:18413-18418.
16. Navia MA, Fitzgerald PMD, McKeever BM, Leu CT, Heimbach JC, Herber WK, Segal IS, Darke PL, Springer JP. 1989. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615-620.
17. Poorman RA, Tomasselli AG, Heinrikson RL, Kezdy FJ. 1991. A cumulative specificity model for proteases from human immunodeficiency virus type 1 and 2, infering from statistical analysis of an extended substrate database. J Biol Chem 266:14554-14561.
18. Ridky TW, Cameron CE, Cameron J, Leis J, Copeland T, Wlodawer A, Weber IT, Harrison RW. 1996. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J Biol Chem 271:4709-4717.
19. Sali A, Veerapandian B, Cooper JB, Moss DS, Hofmann T, Blundell TL. 1992. Domain flexibility in aspartic proteinases. Proteins Struct Funct Genet 12:158-170.
20. Shimada T, Yasuda K, Mori A, Ni H, Mercado-Asis LB, Murase H, Miura K. 1993. Aldosterone binding to mineralocorticoid receptors of mononuclear leukocytes in diabetic subjects. Acta Endocrinol (Copenh) 128:529-535.
21. Silva AM, Cachau RE, Sham HL, Erickson JW. 1996. Inhibition and catalytic mechanism of HIV-1 aspartic protease. J Mol Biol 255:321-346.
22. Suguna K, Bott RR, Padlan EA, Subramanian E, Sheriff S, Cohen GH, Davies DR. 1987. Structure and refinement at 1.8 Å resolution of the aspartic proteinase from Rhizopus chinensis. J Mol Biol 196:877-900.
23. Tronrud DE, Ten Eyck LF, Matthews BW. 1987. An efficient general-purpose least-squares refinement program or macromolecular structures. Acta Crystallogr A 43:489-501.
24. Wlodawer A, Erickson JW. 1993. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 62:543-585.
25. Wlodawer A, Miller M, Jaskolski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SBH. 1989. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science 245:616-621.